CELL C HOLDINGS LIMITED - Dealings by directors and by the company secretary
What this filing means
Cell C has disclosed the acceptance of Long Term Incentive Plan options by two directors and the company secretary, all dated 30 October 2026 at an exercise price of R26.26 per share. Jorge Mendes accepted 587 763 options worth R15 434 656,38, El Kope 179 587 worth R4 715 954,62 and Michelle Robinson 26 878 worth R705 816,28. The awards vest over three years to 31 May 2029 and are subject to performance criteria, so nothing here is earned yet.
Three senior people at Cell C have been given the right to buy shares at a set price in future, rather than being handed shares or cash today. That right only becomes valuable if the company meets performance targets and the share price does well over the next three years. It tells you how management is being paid, not how the business is trading.
Bear case
- Missing evidence: the notice gives no resulting holding, no issued-share count and no vesting outcome, so the size of these awards cannot be measured against anything.
AI-generated summary by SENS-AI, based on the original JSE SENS filing.
SENS-AI conclusion
This is an incentive-award notice, not a signal about the business. Two directors and the company secretary accepted options under the Long Term Incentive Plan at R26.26, the 30-day volume weighted average price to 29 May 2026, with vesting spread over three years to 31 May 2029 and conditional on performance criteria. No shares were bought in the market and no sale is disclosed. The notice does not quantify any earnings or balance-sheet impact from the awards, so their accounting effect cannot be sized from this filing. So what: the earnings picture is untouched by anything here; the audited accounts and the AGM resolutions remain where the real information sits.
The vesting conditions in the LTIP rules determine when the awards vest.
Evidence from the filing
The transaction is acceptance of options, not a market purchase of shares.
“Off market acceptance of options granted in terms of”
The exercise price is set from a historical volume weighted average price.
“*Representing the 30-day volume weighted average price of a Cell C ordinary share, up to and including 29 May 2026, being the”
The awards are conditional and vest over an extended period.
“Vesting of awards occurs over a period of 3 years, to 31 May 2029, subject to the achievement of applicable performance criteria”
The largest single award in the notice.
“Number of options granted : 587 763”
More on Cell C Holdings Limited
Related filings
More from CCD
- CELL C HOLDINGS LIMITED - Availability of B-BBEE compliance report
- CELL C HOLDINGS LIMITED - Change statement on AFS disclosures, availability of annual report and notice of annual general meeting
- CELL C HOLDINGS LIMITED - Cancellation of S604172 - Change statement on AFS disclosures, availability of annual report and notice of annual general meeting
- CELL C HOLDINGS LIMITED - Change statement on AFS disclosures, availability of annual report and notice of annual general meeting
- CELL C HOLDINGS LIMITED - Dealing in securities by a director
Other Director Dealings
- LHCLIFE HEALTHCARE GROUP HOLDINGS LIMITED - Dealings in securities
- TPCTRANSPACO LIMITED - Dealing in Securities by an Associate of a Director
- GRTGROWTHPOINT PROPERTIES LIMITED - Dealings in Securities by Executive Directors, Directors of a Major Subsidiary and Company Secretary
- BYIBYTES TECHNOLOGY GROUP PLC - Notification and Public Disclosure of Transactions by Persons Discharging Managerial Responsibilities
- ABGABSA GROUP LIMITED - DEALING IN SECURITIES BY A PRESCRIBED OFFICER